Visualitza per autor "Espinosa Bravo, Martin"
Ara mostrant els elements 1-3 d 3
-
Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
Feliciano Aguirre, Andrea F; Gonzalez Amaya, Lucila; Garcia Mayea, Yoelsis; Mir Perez, Cristina; Artola, Mireia; Barragán, Nieves; Castellví Vives, Josep; Benavente Norza, Sergio; Ramon y Cajal Agüeras, Santiago; Espinosa Bravo, Martin; Cortés Castan, Javier; Lleonart Pajarin, Matilde (Frontiers Media, 2020-11-03) -
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, Tomás; Antunes de Melo Oliveira, Ana Mafalda; Ciruelos, Eva; Gavilá Gregori, Joaquín; Espinosa Bravo, Martin; Arumí De Dios, Míriam; Bellet Ezquerra, Meritxell; Saura Manich, Cristina (Frontiers Media, 2021-04) -
The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1
Nadal Serrano, Mercedes; Morancho Armisen, Beatriz; Escriva de Romaní Muñoz, Santiago Ignacio; Luque García, Antonio; Espinosa Bravo, Martin; Peg Camara, Vicente; Cortés Castan, Javier; Arribas López, Joaquin Vicente; Bernadó Morales, Cristina; Saura Manich, Cristina; Escorihuela Baez, Marta (MDPI, 2020-03-13)